Finance

Beta
Lists
539523:BOM
Alkem Laboratories Ltd
₹5,255.75
-0.39%
(-20.60) 1D
Jun 5, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 539523...
Open
₹5,306.00
High
₹5,341.15
Low
₹5,223.30
Mkt. cap
627.72B
Avg. vol.
4.28K
Volume
3.86K
Dividend
1.01%
Quarterly dividend
₹13.25
Ex-dividend date
Aug 7, 2026
P/E ratio
27.30
52-wk high
₹5,933.00
52-wk low
₹4,716.75
EPS
₹192.51
Shares outstanding
119.55M
No. of employees
19K
Open
₹5,306.00
High
₹5,341.15
Low
₹5,223.30
Mkt. cap
627.72B
Avg. vol.
4.28K
Volume
3.86K
Dividend
1.01%
Quarterly dividend
₹13.25
Ex-dividend date
Aug 7, 2026
P/E ratio
27.30
52-wk high
₹5,933.00
52-wk low
₹4,716.75
EPS
₹192.51
Shares outstanding
119.55M
No. of employees
19K
News stories
From sources across the web
Profile
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
About Alkem Laboratories Ltd
CEO-
Employees18.8K
Founded1973
HeadquartersMumbai, Maharashtra, India
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
33.71B
40.01B
37.37B
36.03B
Cost of goods sold
11.71B
14.01B
12.73B
12.48B
Cost of revenue
11.71B
14.01B
12.73B
12.48B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.93B
7.10B
7.22B
7.12B
Operating expense
15.49B
17.73B
17.31B
19.44B
Total operating expenses
27.20B
31.74B
30.04B
31.92B
Operating income
6.51B
8.27B
7.33B
4.12B
Other non operating income
1.36B
1.04B
1.43B
2.00B
EBT including unusual items
7.71B
8.95B
7.81B
4.22B
EBT excluding unusual items
7.58B
8.95B
8.33B
5.57B
Income tax expense
1.03B
1.16B
1.28B
1.71B
Effective tax rate
13.33%
12.98%
16.35%
40.53%
Other operating expenses
7.68B
9.69B
9.15B
11.26B
Net income
6.64B
7.65B
6.36B
2.36B
Net profit margin
19.70%
19.12%
17.02%
6.56%
Earnings per share
54.62
63.99
56.88
26.50
Interest and investment income
-
-
-
-
Interest expense
-297.80M
-350.20M
-421.00M
-538.80M
Net interest expenses
-297.80M
-350.20M
-421.00M
-538.80M
Depreciation and amortization charges
876.80M
936.10M
950.10M
1.06B
EBITDA
7.29B
9.18B
8.11B
5.07B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more